Semaglutide, the active ingredient in Ozempic, and other drugs in the same class have revolutionized the treatment of obesity and type 2 diabetes.Now, a clinical trial suggests the medicines can ...

This approval makes Ozempic the first GLP-1 treatment for patients with both conditions. Chronic kidney disease is common in people with diabetes. About one in three adults with diabetes have ...

Type 1 and type 2 diabetes are driven by very different mechanisms. In type 2 , cells in the pancreas that make insulin become less sensitive to blood sugar and produce less insulin in response.